1. Home
  2. NTCT vs VCEL Comparison

NTCT vs VCEL Comparison

Compare NTCT & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NetScout Systems Inc.

NTCT

NetScout Systems Inc.

HOLD

Current Price

$27.68

Market Cap

2.0B

Sector

Technology

ML Signal

HOLD

Logo Vericel Corporation

VCEL

Vericel Corporation

HOLD

Current Price

$39.27

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTCT
VCEL
Founded
1984
1989
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.0B
IPO Year
1999
1997

Fundamental Metrics

Financial Performance
Metric
NTCT
VCEL
Price
$27.68
$39.27
Analyst Decision
Buy
Strong Buy
Analyst Count
2
5
Target Price
$31.00
$57.50
AVG Volume (30 Days)
405.7K
520.7K
Earning Date
02-05-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
236.54
EPS
1.24
0.25
Revenue
$862,770,000.00
$258,716,999.00
Revenue This Year
$5.90
$17.86
Revenue Next Year
$2.62
$18.55
P/E Ratio
$22.47
$158.71
Revenue Growth
9.60
14.05
52 Week Low
$18.12
$29.24
52 Week High
$30.67
$63.00

Technical Indicators

Market Signals
Indicator
NTCT
VCEL
Relative Strength Index (RSI) 53.34 55.83
Support Level $26.70 $35.85
Resistance Level $28.29 $39.07
Average True Range (ATR) 0.78 1.86
MACD 0.01 0.04
Stochastic Oscillator 62.96 61.79

Price Performance

Historical Comparison
NTCT
VCEL

About NTCT NetScout Systems Inc.

NetScout Systems Inc is a provider of service assurance and cybersecurity solutions to enterprise and government networks. It bases its solutions on proprietary adaptive service intelligence technology, which helps customers monitor and identify performance issues and provides insight into network-based security threats. These solutions also deliver real-time and historical information, which provides insight to restore service and understand the quality of user experience. The company derives revenue from the sale of network management tools and security solutions. Its geographical regions include USA, which derives maximum revenue, Europe, Asia, and Rest of the World.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: